Frazier Life Sciences Management as of March 31, 2025
Portfolio Holdings for Frazier Life Sciences Management
Frazier Life Sciences Management holds 47 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 15.1 | $330M | 16M | 20.47 | |
| Mirum Pharmaceuticals (MIRM) | 14.0 | $306M | 6.8M | 45.05 | |
| Verona Pharma Sponsored Ads (VRNA) | 10.0 | $220M | 3.5M | 63.49 | |
| Arcutis Biotherapeutics (ARQT) | 6.3 | $137M | 8.8M | 15.64 | |
| Bridgebio Pharma (BBIO) | 6.0 | $131M | 3.8M | 34.57 | |
| Krystal Biotech (KRYS) | 5.7 | $124M | 689k | 180.30 | |
| Disc Medicine (IRON) | 4.0 | $87M | 1.8M | 49.64 | |
| Tarsus Pharmaceuticals (TARS) | 3.3 | $72M | 1.4M | 51.37 | |
| Trevi Therapeutics (TRVI) | 2.9 | $65M | 10M | 6.29 | |
| Phathom Pharmaceuticals (PHAT) | 2.9 | $63M | 10M | 6.27 | |
| Kalvista Pharmaceuticals (KALV) | 2.6 | $56M | 4.9M | 11.54 | |
| Maze Therapeatics (MAZE) | 2.1 | $46M | 4.1M | 11.01 | |
| Mbx Biosciences (MBX) | 2.0 | $44M | 6.0M | 7.38 | |
| Rhythm Pharmaceuticals (RYTM) | 1.6 | $36M | 679k | 52.97 | |
| Soleno Therapeutics (SLNO) | 1.6 | $36M | 499k | 71.45 | |
| Revolution Medicines (RVMD) | 1.6 | $35M | 998k | 35.36 | |
| Savara (SVRA) | 1.5 | $32M | 12M | 2.77 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $31M | 1.1M | 29.30 | |
| Erasca (ERAS) | 1.4 | $31M | 23M | 1.37 | |
| Ultragenyx Pharmaceutical (RARE) | 1.1 | $24M | 659k | 36.21 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $21M | 133k | 155.86 | |
| Vaxcyte (PCVX) | 0.9 | $20M | 539k | 37.76 | |
| Alkermes SHS (ALKS) | 0.9 | $20M | 601k | 33.02 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.9 | $19M | 690k | 27.99 | |
| Cg Oncology (CGON) | 0.9 | $19M | 770k | 24.49 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.8 | $18M | 7.8M | 2.25 | |
| Merus N V (MRUS) | 0.7 | $16M | 373k | 42.09 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $16M | 525k | 29.52 | |
| Hillevax | 0.7 | $15M | 11M | 1.45 | |
| Dyne Therapeutics (DYN) | 0.7 | $15M | 1.4M | 10.46 | |
| Zai Lab Adr (ZLAB) | 0.6 | $13M | 350k | 36.14 | |
| Immunocore Hldgs Ads (IMCR) | 0.4 | $8.9M | 301k | 29.67 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $7.9M | 1.4M | 5.58 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $7.8M | 470k | 16.61 | |
| Design Therapeutics (DSGN) | 0.3 | $7.5M | 2.0M | 3.86 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $7.2M | 1.1M | 6.67 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $7.2M | 4.6M | 1.55 | |
| Oruka Therapeutics (ORKA) | 0.3 | $6.0M | 583k | 10.26 | |
| Allogene Therapeutics (ALLO) | 0.3 | $5.6M | 3.9M | 1.46 | |
| Immatics SHS (IMTX) | 0.3 | $5.6M | 1.2M | 4.51 | |
| Cogent Biosciences (COGT) | 0.3 | $5.6M | 937k | 5.99 | |
| Adverum Biotechnologies Com New (ADVM) | 0.2 | $4.7M | 1.1M | 4.37 | |
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.2 | $4.5M | 500k | 8.99 | |
| Macrogenics (MGNX) | 0.2 | $4.0M | 3.2M | 1.27 | |
| Lexeo Therapeutics (LXEO) | 0.2 | $3.3M | 956k | 3.47 | |
| Silence Therapeutics Ads (SLN) | 0.1 | $3.2M | 1.1M | 2.82 | |
| Elevation Oncology (ELEV) | 0.1 | $1.6M | 6.0M | 0.26 |